Patent Expiry
Patent/Exclusivity Expiry: CABOMETYX
- Drug
- CABOMETYX
Other upcoming events for PTCT
Phase 3 ReadoutPhase 3 Topline: A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
Phase 3 ReadoutPhase 3 Topline: Long-Term Open-Label Study to Assess the Safety and Efficacy of Vatiquinone in Patients With Friedre
Phase 3 ReadoutPhase 3 Topline: A Phase 3b Open-Label Study of Long-Term Neurocognitive Outcomes in Children With Phenylketonuria Tr
Patent ExpiryPatent/Exclusivity Expiry: COMETRIQ
Phase 3 ReadoutPhase 3 Topline: Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sar
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.